T. Wong

Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups.

W. Greenhalf, J. Neoptolemos, G. Lancaster, 2005, Gastroenterology.

Molecular Diagnosis of Early Pancreatic Ductal Adenocarcinoma in High-Risk Patients

W. Greenhalf, J. Neoptolemos, R. Sutton, 2001, Pancreatology.

Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma

Wei Zhao, S. Moschos, P. Googe, 2022, medRxiv.